Beau R. Webber

Beau R. Webber

University of Minnesota-Twin Cities

H-index: 26

North America-United States

About Beau R. Webber

Beau R. Webber, With an exceptional h-index of 26 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Minnesota-Twin Cities, specializes in the field of Genome Editing, Stem Cell Biology, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development and Testing of a Versatile Genome Editing Application Reporter (V-GEAR) System

Engineering Memory T Cells as a platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders

Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing

Enhancing efficiency of targeted gene knockin by base editors

Intracellular genomic transplant and methods of therapy

Delivery of molecules to cells using trogocytosis and engineered cells

Engineered immune cells for reagent delivery

Beau R. Webber Information

University

Position

Assistant Professor

Citations(all)

2719

Citations(since 2020)

2095

Cited By

1239

hIndex(all)

26

hIndex(since 2020)

23

i10Index(all)

39

i10Index(since 2020)

35

Email

University Profile Page

University of Minnesota-Twin Cities

Google Scholar

View Google Scholar Profile

Beau R. Webber Skills & Research Interests

Genome Editing

Stem Cell Biology

Immunotherapy

Top articles of Beau R. Webber

Title

Journal

Author(s)

Publication Date

Development and Testing of a Versatile Genome Editing Application Reporter (V-GEAR) System

Molecular Therapy Methods & Clinical Development

Evan W Kleinboehl

Kanut Laoharawee

Walker S Lahr

Jacob D Jensen

Joseph J Peterson

...

2024/4/24

Engineering Memory T Cells as a platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders

bioRxiv

Evan Kleinboehl

Kanut Laoharawee

Jacob D Jensen

Joseph J Peterson

Nicholas J Slipek

...

2024

Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

Molecular Therapy

Joseph G Skeate

Emily J Pomeroy

Nicholas J Slipek

Bryan J Jones

Bryce J Wick

...

2024/4/16

Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing

bioRxiv

Minjing Wang

Joshua B Krueger

Alexandria K Gilkey

Erin M Stelljes

Mitchell G Kluesner

...

2024

Enhancing efficiency of targeted gene knockin by base editors

2024/3/28

Intracellular genomic transplant and methods of therapy

2024/2/20

Delivery of molecules to cells using trogocytosis and engineered cells

2024/2/8

Engineered immune cells for reagent delivery

2024/1/25

Tumor-infiltrating lymphocytes: Prognostic considerations and current trials as adoptive cell therapy

Timothy D Folsom

Branden S Moriarity

Timothy K Starr

Emil Lou

Beau R Webber

2023/1/1

CRISPR-Cas9 base editors and their current role in human therapeutics

Walker S Lahr

Christopher J Sipe

Joseph G Skeate

Beau R Webber

Branden S Moriarity

2023/3/1

ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS

2023/8/31

Modified cells and methods of therapy

2023/2/21

Ablation of SYK kinase from expanded primary human NK cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production

The Journal of Immunology

James D Dahlvang

Jenna K Dick

Jules A Sangala

Philippa R Kennedy

Emily J Pomeroy

...

2023/4/15

Germline T cell receptor exchange results in physiological T cell development and function

Nature communications

Meagan R Rollins

Jackson F Raynor

Ebony A Miller

Jonah Z Butler

Ellen J Spartz

...

2023/2/1

CAT-248, an allogeneic CD70-directed CAR-NK cell therapy effectively controls CD70-positive tumor xenografts

Cancer Research

Bashar Hamza

Eugene Choi

Dominic Picarella

Finola Moore

Angela Nunez

...

2023/4/4

Methods, compositions, and kits for expanding natural killer cells

2023/12/14

Engineering a hyperactive TcBuster transposase for efficient gene delivery for cell therapy applications

Bryan J Jones

Blake Barnes

Trevor Zarecki

Joseph G Skeate

Emily J Pomeroy

...

2023

254 A systems genomics approach to identify novel drug targets of Ewing sarcoma through ancestry-informed human iPSC modeling

Journal of Clinical and Translational Science

Rachel M Moss

Kelsie Becklin

Lauren J Mills

Branden S Moriarity

Beau R Webber

...

2023/4

Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair

Nature Biomedical Engineering

Beau R Webber

Matthew J Johnson

Joseph G Skeate

Nicholas J Slipek

Walker S Lahr

...

2023/12/13

3140–HEMATOPOIETIC TRANSCRIPTION FACTOR MRNA IN THE ABSENCE OF HEMATOPOIETIC CYTOKINES YIELDS IPSC-CD34 CELLS WITH INCREASED T CELL POTENTIAL

Experimental Hematology

Brett Napiwocki

Lage von Dissen

Anthony Trombetta

Branden Moriarity

Beau Webber

2023/1/1

See List of Professors in Beau R. Webber University(University of Minnesota-Twin Cities)